Jpmorgan Chase & Co »

Denali Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 183k 21.46
2023-09-30 $3.5M 168k 20.63
2023-06-30 $4.7M 158k 29.51
2023-03-31 $1.4M 1.1k 1302.35
2022-12-31 $5.1M 184k 27.82
2022-06-30 $2.9M 100k 29.43
2022-03-31 $3.1M 97k 32.21
2021-12-31 $3.7M 83k 44.59
2021-03-31 $4.3M 75k 57.09
2020-12-31 $28M 331k 83.75
2020-09-30 $11M 309k 36.30
2020-06-30 $5.9M 245k 24.18
2020-03-31 $3.1M 176k 17.51
2019-12-31 $1.4M 78k 17.43
2019-09-30 $241k 16k 15.33
2019-06-30 $271k 13k 20.58
2019-03-31 $257k 11k 23.22
2018-12-31 $240k 12k 20.62
2018-09-30 $229k 11k 21.70
2018-06-30 $52k 3.4k 15.14
2018-03-31 $64k 3.3k 19.69